Navigation Links
SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008
Date:4/21/2008

DUBLIN, Calif., April 21 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2008 first quarter financial results on Monday, April 28, 2008. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.

A press release will be transmitted to the news media immediately following the close of the market on April 28, 2008. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

Contacts:

SuperGen, Inc.

Timothy L. Enns

S.V.P., Corporate Communications & Business Development

(925) 560-0100

tenns@supergen.com

SuperGen, Inc.

Mary M. Vegh

Manager, Investor Relations

(925) 560-2845

mary.vegh@supergen.com


'/>"/>
SOURCE SuperGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
2. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
3. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
4. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
5. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
6. Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
7. Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement
8. US Oncology Announces Resignation of Chief Financial Officer
9. UNC-Chapel Hill, Hamner Institutes Announce Partnership to Accelerate Basic, Translational Research
10. Biotherm Announces a Unique Dermobiotic Three-Step Anti-Cellulite Slimming Treatment
11. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... ... electronic informed consent (eConsent) solution that simplifies research studies, accelerates study startup, and ... of Quorum, Q Consent™ is the first and only IRB-integrated eConsent solution ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... a comprehensive rebrand and a name change to Fluence Analytics. , ... laboratory monitoring of polymer and biopharmaceutical manufacturing processes and R&D applications. The ...
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished resource ... today announces the appointment of Thomas C. Seoh ... ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive Chairman ... to Kinexum clients. Thomas Seoh ... the Kinexum mission and lead the firm,s remarkable team ...
(Date:4/26/2017)... ... ... LABS, Inc. (LABS) announced in December 2016 that two new Zika Virus ... (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for IgM and IgG ZIKV antibodies. ... under an Investigational New Drug (IND) study protocol. , Now, as part of ...
Breaking Biology Technology:
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):